Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic

• Sponsor: Towson University (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT04720118
• Collaborator: (none)
• Enrollment: 150
• Location: 1
• Anticipated Duration (Months): 2
• Patients Per Site Per Month: 74.8

Study Details

Study Description

Brief Summary

The purpose of this research study is to examine the relationship between personal characteristics and satisfaction with care in those diagnosed with Parkinson's disease during the COVID-19 pandemic. Participants will take 4 different surveys regarding their satisfaction with care throughout the duration of the COVID-19 pandemic. The surveys in total should not take more than 30 minutes to complete

Condition or Disease	Intervention/Treatment	Phase
Parkinson Disease; Covid19; Satisfaction, Patient; Quality of Life	Other: No Intervention

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 150 participants
• Observational Model: Other
• Time Perspective: Cross-Sectional
• Official Title: Does Locus of Control Affect Satisfaction and Quality of Life During COVID - 19?
• Actual Study Start Date: Mar 1, 2021
• Anticipated Primary Completion Date: Apr 1, 2021
• Anticipated Study Completion Date: May 1, 2021

Outcome Measures

Primary Outcome Measures

1. Measure of the relationship between Locus of Control and Quality of Life [1 year]

   Participants will take the Multidimensional Health Locus of Control (MHLC) Scale. This will determine if the participant has more of an internal or external locus of control. Participants will also take the Quality of Life Scale- U.S Parkinson's Disease Questionnaire (PDQ-39) to determine the quality of life they have been experiencing throughout the COVID-19 pandemic. Based on the results of both surveys, the researchers will be able to determine if external locus of control or internal locus of control leads to a better quality of life in PD patients throughout the COVID-19 pandemic.

2. Measure of secondary control and satisfaction with care [1 year]

   Participants will take the Multidimensional Health Locus Control (MHLC) scale. This will determine what type of control is most present in the participant's life. Additionally, participant's will take the Short Form Patient Satisfaction Questionnaire (PSQ-18). This will determine how satisfied participants are with their healthcare providers throughout the COVID-19 pandemic. Based off of the responses to the surveys, the researcher will be able to determine whether a higher or lower secondary control yields a higher satisfaction.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• 18 years or older

• Diagnosed with Parkinson's Disease

• Must be able to complete the surveys without any help

Exclusion Criteria:

• Under the age of 18

• Not diagnosed with Parkinson's Disease

• Unable to complete the surveys without help

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Towson University	Towson	Maryland	United States	21204

Sponsors and Collaborators

• Towson University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

• Qualtrics Link to the surveys for the study

Publications

None provided.

• Responsible Party: MacKenzie Forbes, Graduate Student, Towson University
• ClinicalTrials.gov Identifier: NCT04720118
• Other Study ID Numbers: 1352
• First Posted: Jan 22, 2021
• Last Update Posted: Apr 1, 2021
• Last Verified: Mar 1, 2021

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: COVID-19; Parkinson Disease

Study Results

No Results Posted as of Apr 1, 2021